Literature DB >> 18690360

Assessment of thrombin generation II: Validation of the Calibrated Automated Thrombogram in platelet-poor plasma in a clinical laboratory.

Henri M H Spronk, Arne W J H Dielis, Erik De Smedt, René van Oerle, Diane Fens, Martin H Prins, Karly Hamulyák, Hugo ten Cate.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18690360

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  21 in total

1.  Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth?

Authors:  S Koutroumpi; L Spiezia; N Albiger; M Barbot; M Bon; S Maggiolo; S Gavasso; P Simioni; A Frigo; F Mantero; C Scaroni
Journal:  Pituitary       Date:  2014-02       Impact factor: 4.107

2.  Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia.

Authors:  Marijke C Trappenburg; Muriel van Schilfgaarde; Marina Marchetti; Henri M Spronk; Hugo ten Cate; Anja Leyte; Wim E Terpstra; Anna Falanga
Journal:  Haematologica       Date:  2009-06-08       Impact factor: 9.941

3.  Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer-Associated Thrombosis: The Observational ROADMAP-CAT Study.

Authors:  Konstantinos Syrigos; Dimitra Grapsa; Rabiatou Sangare; Ilias Evmorfiadis; Annette K Larsen; Patrick Van Dreden; Paraskevi Boura; Andriani Charpidou; Elias Kotteas; Theodoros N Sergentanis; Ismail Elalamy; Anna Falanga; Grigoris T Gerotziafas
Journal:  Oncologist       Date:  2018-08-13

Review 4.  Essential thrombocythemia: a hemostatic view of thrombogenic risk factors and prognosis.

Authors:  Mohsen Maleknia; Saeid Shahrabi; Majid Ghanavat; Tina Vosoughi; Najmaldin Saki
Journal:  Mol Biol Rep       Date:  2020-05-30       Impact factor: 2.316

5.  Thrombin generation in the Glasgow Myocardial Infarction Study.

Authors:  Machiel Smid; Arne W J H Dielis; Henri M H Spronk; Ann Rumley; Rene van Oerle; Mark Woodward; Hugo ten Cate; Gordon Lowe
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

6.  The hypercoagulable profile of patients with stent thrombosis.

Authors:  R Loeffen; T C Godschalk; R van Oerle; H M H Spronk; C M Hackeng; J M ten Berg; H ten Cate
Journal:  Heart       Date:  2015-05-21       Impact factor: 5.994

Review 7.  A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis.

Authors:  Marcus D Lancé
Journal:  Thromb J       Date:  2015-01-12

8.  Effects of Fibrinogen Concentrate on Thrombin Generation, Thromboelastometry Parameters, and Laboratory Coagulation Testing in a 24-Hour Porcine Trauma Model.

Authors:  Christian Zentai; Cristina Solomon; Paola E J van der Meijden; Henri M H Spronk; Jonas Schnabel; Rolf Rossaint; Oliver Grottke
Journal:  Clin Appl Thromb Hemost       Date:  2015-05-06       Impact factor: 2.389

9.  Platelet dysfunction in thrombosis patients treated with vitamin K antagonists and recurrent bleeding.

Authors:  Paola E J van der Meijden; Annemieke C Bouman; Marion A H Feijge; René van Oerle; Henri M H Spronk; Karly Hamulyák; Arina J ten Cate-Hoek; Hugo ten Cate; Johan W M Heemskerk
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

10.  D-dimer, thrombin generation, and risk of a first venous thrombosis in the elderly.

Authors:  Huijie Wang; Frits R Rosendaal; Mary Cushman; Astrid van Hylckama Vlieg
Journal:  Res Pract Thromb Haemost       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.